p130Rb2 and p27kip1 cooperate to control mobilization of angiogenic progenitors from the bone marrow

Anxo Vidal, Stergios Zacharoulis, Wenjun Guo, David Shaffer, Filippo Giancotti, Anna H. Bramley, Carmen De La Hoz, Kristian K. Jensen, Daniel Kato, Daniel D. MacDonald, Joseph Knowles, Nancy Yeh, Lawrence A. Frohman, Shahin Rafii, David Lyden, Andrew Koff

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Neoangiogenesis involves both bone marrow-derived myelomonocytic and endothelial progenitor cells as well as endothelial cells coopted from surrounding vessels. Cytokines induce these cells to proliferate, migrate, and exit the cell cycle to establish the vasculature; however, which cell cycle regulators play a role in these processes is largely unknown. Here, we report that mice lacking the cell cycle inhibitors p130 and p27 show defects in tumor neoangiogenesis, both in xenografts and spontaneously arising tumors. This defect is associated with impaired mobilization of endothelial and myelomonocytic angiogenic progenitors from the bone marrow. This article documents the role of these molecules in angiogenesis and further suggests that cell expansion and mobilization from the bone marrow of angiogenic precursors are separable events.

Original languageEnglish (US)
Pages (from-to)6890-6895
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume102
Issue number19
DOIs
StatePublished - May 10 2005
Externally publishedYes

Fingerprint

Cell Cycle
Bone Marrow
Heterografts
Neoplasms
Endothelial Cells
Cytokines
Endothelial Progenitor Cells

Keywords

  • Angiogenesis
  • Cyclin-dependent kinase inhibitors
  • Stem cell

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

p130Rb2 and p27kip1 cooperate to control mobilization of angiogenic progenitors from the bone marrow. / Vidal, Anxo; Zacharoulis, Stergios; Guo, Wenjun; Shaffer, David; Giancotti, Filippo; Bramley, Anna H.; De La Hoz, Carmen; Jensen, Kristian K.; Kato, Daniel; MacDonald, Daniel D.; Knowles, Joseph; Yeh, Nancy; Frohman, Lawrence A.; Rafii, Shahin; Lyden, David; Koff, Andrew.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, No. 19, 10.05.2005, p. 6890-6895.

Research output: Contribution to journalArticle

Vidal, A, Zacharoulis, S, Guo, W, Shaffer, D, Giancotti, F, Bramley, AH, De La Hoz, C, Jensen, KK, Kato, D, MacDonald, DD, Knowles, J, Yeh, N, Frohman, LA, Rafii, S, Lyden, D & Koff, A 2005, 'p130Rb2 and p27kip1 cooperate to control mobilization of angiogenic progenitors from the bone marrow', Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 19, pp. 6890-6895. https://doi.org/10.1073/pnas.0405823102
Vidal, Anxo ; Zacharoulis, Stergios ; Guo, Wenjun ; Shaffer, David ; Giancotti, Filippo ; Bramley, Anna H. ; De La Hoz, Carmen ; Jensen, Kristian K. ; Kato, Daniel ; MacDonald, Daniel D. ; Knowles, Joseph ; Yeh, Nancy ; Frohman, Lawrence A. ; Rafii, Shahin ; Lyden, David ; Koff, Andrew. / p130Rb2 and p27kip1 cooperate to control mobilization of angiogenic progenitors from the bone marrow. In: Proceedings of the National Academy of Sciences of the United States of America. 2005 ; Vol. 102, No. 19. pp. 6890-6895.
@article{e98af8ea28984253b693fa991ef7e554,
title = "p130Rb2 and p27kip1 cooperate to control mobilization of angiogenic progenitors from the bone marrow",
abstract = "Neoangiogenesis involves both bone marrow-derived myelomonocytic and endothelial progenitor cells as well as endothelial cells coopted from surrounding vessels. Cytokines induce these cells to proliferate, migrate, and exit the cell cycle to establish the vasculature; however, which cell cycle regulators play a role in these processes is largely unknown. Here, we report that mice lacking the cell cycle inhibitors p130 and p27 show defects in tumor neoangiogenesis, both in xenografts and spontaneously arising tumors. This defect is associated with impaired mobilization of endothelial and myelomonocytic angiogenic progenitors from the bone marrow. This article documents the role of these molecules in angiogenesis and further suggests that cell expansion and mobilization from the bone marrow of angiogenic precursors are separable events.",
keywords = "Angiogenesis, Cyclin-dependent kinase inhibitors, Stem cell",
author = "Anxo Vidal and Stergios Zacharoulis and Wenjun Guo and David Shaffer and Filippo Giancotti and Bramley, {Anna H.} and {De La Hoz}, Carmen and Jensen, {Kristian K.} and Daniel Kato and MacDonald, {Daniel D.} and Joseph Knowles and Nancy Yeh and Frohman, {Lawrence A.} and Shahin Rafii and David Lyden and Andrew Koff",
year = "2005",
month = "5",
day = "10",
doi = "10.1073/pnas.0405823102",
language = "English (US)",
volume = "102",
pages = "6890--6895",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "19",

}

TY - JOUR

T1 - p130Rb2 and p27kip1 cooperate to control mobilization of angiogenic progenitors from the bone marrow

AU - Vidal, Anxo

AU - Zacharoulis, Stergios

AU - Guo, Wenjun

AU - Shaffer, David

AU - Giancotti, Filippo

AU - Bramley, Anna H.

AU - De La Hoz, Carmen

AU - Jensen, Kristian K.

AU - Kato, Daniel

AU - MacDonald, Daniel D.

AU - Knowles, Joseph

AU - Yeh, Nancy

AU - Frohman, Lawrence A.

AU - Rafii, Shahin

AU - Lyden, David

AU - Koff, Andrew

PY - 2005/5/10

Y1 - 2005/5/10

N2 - Neoangiogenesis involves both bone marrow-derived myelomonocytic and endothelial progenitor cells as well as endothelial cells coopted from surrounding vessels. Cytokines induce these cells to proliferate, migrate, and exit the cell cycle to establish the vasculature; however, which cell cycle regulators play a role in these processes is largely unknown. Here, we report that mice lacking the cell cycle inhibitors p130 and p27 show defects in tumor neoangiogenesis, both in xenografts and spontaneously arising tumors. This defect is associated with impaired mobilization of endothelial and myelomonocytic angiogenic progenitors from the bone marrow. This article documents the role of these molecules in angiogenesis and further suggests that cell expansion and mobilization from the bone marrow of angiogenic precursors are separable events.

AB - Neoangiogenesis involves both bone marrow-derived myelomonocytic and endothelial progenitor cells as well as endothelial cells coopted from surrounding vessels. Cytokines induce these cells to proliferate, migrate, and exit the cell cycle to establish the vasculature; however, which cell cycle regulators play a role in these processes is largely unknown. Here, we report that mice lacking the cell cycle inhibitors p130 and p27 show defects in tumor neoangiogenesis, both in xenografts and spontaneously arising tumors. This defect is associated with impaired mobilization of endothelial and myelomonocytic angiogenic progenitors from the bone marrow. This article documents the role of these molecules in angiogenesis and further suggests that cell expansion and mobilization from the bone marrow of angiogenic precursors are separable events.

KW - Angiogenesis

KW - Cyclin-dependent kinase inhibitors

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=21044450038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21044450038&partnerID=8YFLogxK

U2 - 10.1073/pnas.0405823102

DO - 10.1073/pnas.0405823102

M3 - Article

C2 - 15867156

AN - SCOPUS:21044450038

VL - 102

SP - 6890

EP - 6895

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 19

ER -